
Pfizer (PFE) Shares Gained 1.72% After Hours as Company’s Coronavirus Drug Looks Promising
Pfizer had initially planned to enter clinical trials for its coronavirus drug by the end of the year. Now it hopes to start the trials in the third quarter. Pfizer shares price is rising.